Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BD Biosciences Launches BD FACSJazz™ Cell Sorting System

Published: Thursday, June 28, 2012
Last Updated: Wednesday, June 27, 2012
Bookmark and Share
New, affordable flow cytometer cell sorter expands access to wider range of life science applications.

BD Biosciences has announced the launch of the BD FACSJazz™ Cell Sorting System, a next-generation flow cytometer that simplifies cellular isolation and analysis for researchers requiring high sample integrity.

Occupying 20" x 20" (51 cm x 51 cm) of benchtop space, the new sorter features high sensitivity to identify and isolate target cells for up to eight parameters.

"As a leader in cell analysis, BD's goal is to make advanced cell isolation and sorting accessible to all researchers, with all levels of experience," said Alberto Mas, Worldwide President, BD Biosciences.

Mas continued, "The BD FACSJazz Cell Sorting System offers, for the first time, an extremely powerful tool for the identification and isolation of single or multiple cells even from complex or extremely rare cell populations right from the benchtop. With application across a number of applications, we believe that this product will complement the recent and very rapid advances in genomic studies where sample integrity is critical for next-generation sequencing and sequence detection."

The new BD FACSJazz Cell Sorting System will have broad utility for next-generation genomic studies.

The system is capable of identifying, characterizing and isolating single or multiple cells and depositing them in 96 and 384 well plates with precision, accuracy and rapidity.

The BD FACSJazz Cell Sorting System incorporates customer input from a 2011 global early access program.

As a result, refinements were made to enhance usability and ease of use.

In addition, a violet laser and pulse processing were added to the offering to enhance live dead cell discrimination and cell cycle analysis.

The system has many innovative features that simplify sorting such as digital controls and factory-optimized settings for the precise isolation of cells.

In addition, the intuitive BD FACS Sortware was developed explicitly for cell sorting to simplify workflow to isolate cells into tubes, or plates as single or multiple cells.

The BD FACSJazz Cell Sorting System can be configured to support up to six colors with eight parameters.

This system includes a standard blue laser but can be additionally configured with an optional red and/or a violet laser.

It is also available with an optional, custom-designed biological safety cabinet.

The custom enclosure has been verified by Baker Company to meet personnel and product protection standards for both a Class II Type A2 biosafety cabinet and National Sanitation Foundation International Standard 49.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BD Receives FDA Clearance for Gastroenteritis Test
The FDA-cleared BD MAX™ Enteric Bacterial Panel for use on the BD MAX System.
Monday, May 12, 2014
BD Collaborates with CME Medical
Collaboration to increase coverage in the UK and Ireland and to provide expanded specialist support to its growing Saf-T-Intima™ customer base.
Sunday, January 12, 2014
BD Helps to Support the Implementation of New Sharps Instruments in Healthcare Regulations
Legislation in place to protect healthcare workers from sharps injuries as a result of new EU Directive on sharps injury prevention.
Thursday, June 13, 2013
New IVD Product is Designed to Improve Prevention and Control of GBS in Newborns
BD MAX™ GBS assay receives FDA clearance and CLIA moderate complexity test categorization.
Wednesday, March 28, 2012
BD Diagnostics and Bruker Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing
BD Diagnostics and Bruker Daltonics Inc. have announced an international co-development and co-marketing collaboration that will promote an emerging, integrated approach to bacterial and fungal identification and antimicrobial susceptibility testing.
Friday, February 11, 2011
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!